awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38222466-6857060F-F9D3-465E-9C6C-E55C8F87CB7D
Q38222466-6857060F-F9D3-465E-9C6C-E55C8F87CB7D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38222466-6857060F-F9D3-465E-9C6C-E55C8F87CB7D
Phase 1 trial design: is 3 + 3 the best?
P2860
Q38222466-6857060F-F9D3-465E-9C6C-E55C8F87CB7D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38222466-6857060F-F9D3-465E-9C6C-E55C8F87CB7D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b27e17d2af956bcc1a8190a8cbf84c2116c50e5c
P2860
Dose-finding with two agents in Phase I oncology trials.